gevokizumab
收藏DataONE2023-06-18 更新2024-06-08 收录
下载链接：
https://search.dataone.org/view/sha256:8029714e99f4356199c1fbfaa15edde8c0d9b495dba24308daa08f3af1c306a4
下载链接
链接失效反馈官方服务：
资源简介：
Gevokizumab (XOMA 052) (Box 1) is a potent monoclonal antibody (mAb), developed by XOMA Corporation, with unique allosteric modulating properties and the potential to treat patients with a wide variety of diseases. Gevokizumab binds strongly to interleukin-1 beta (IL-1β), a pro-inflammatory cytokine, which has been implicated in cardiovascular conditions, lung cancer, and auto-inflammatory diseases.
创建时间：
2023-11-08
